08:00 , Mar 6, 2000 |  BC Week In Review  |  Company News

Beaufor Ipsen S.A., West Pharmaceutical deal

WST will develop nasal drug delivery formulations of a Beaufor compound to treat osteoporosis for use in Beaufor's U.K. clinical trials. If the product meets performance criteria, the companies anticipate signing a development agreement. Beaufor...